Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Bennett

Showing results (411-420 of 566) with videos related to

Pageof 57
Sort By:
Molecular Urology|January 13, 2001
Terazosin for vesicosphincter dyssynergia in spinal cord-injured male patientsJ K Bennett, J Foote, T R El-Leithy, et al.
Hepatology (Baltimore, Md.)|November 1, 1986
Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?H C Mitchison, M F Bassendine, A Hendrick, et al.
Journal of the Neurological Sciences|September 29, 2004
Recurrent demyelinating myelitis associated with hepatitis C viral infectionAmrit K Grewal, M Beatriz Lopes, Carl L Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials GroupM J Moore, E W Winquist, N Murray, et al.
Advanced Healthcare Materials|April 23, 2014
Carbon nanotube composites as multifunctional substrates for in situ actuation of differentiation of human neural stem cellsJohn Landers, Jeffrey T Turner, Greg Heden, et al.
Journal of the American Dietetic Association|October 1, 1996
Assessing fruit and vegetable consumption in a 5 a day study targeting rural blacks: the issue of portion sizeM Kramish Campbell, B Polhamus, J W McClelland, et al.
Drug Discovery Today|August 29, 2003
Drug discovery in the ubiquitin regulatory pathwayBrian R Wong, Francesco Parlati, Kunbin Qu, et al.
The Journal of Rheumatology|August 1, 1995
Patient utilities in fibromyalgia and the association with other outcome measuresC Bakker, M Rutten, M van Santen-Hoeufft, et al.
The Journal of Biological Chemistry|June 6, 1998
Protease resistance of syntaxin.SNAP-25.VAMP complexes. Implications for assembly and structureM A Poirier, J C Hao, P N Malkus, et al.
Plos One|January 5, 2012
Molecular mechanisms of bortezomib resistant adenocarcinoma cellsErika Suzuki, Susan Demo, Edgar Deu, et al.
Pageof 57

Showing results (411-420 of 566) with videos related to

Sort By:
Pageof 57
Molecular Urology|January 13, 2001
Terazosin for vesicosphincter dyssynergia in spinal cord-injured male patientsJ K Bennett, J Foote, T R El-Leithy, et al.
Hepatology (Baltimore, Md.)|November 1, 1986
Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?H C Mitchison, M F Bassendine, A Hendrick, et al.
Journal of the Neurological Sciences|September 29, 2004
Recurrent demyelinating myelitis associated with hepatitis C viral infectionAmrit K Grewal, M Beatriz Lopes, Carl L Berg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials GroupM J Moore, E W Winquist, N Murray, et al.
Advanced Healthcare Materials|April 23, 2014
Carbon nanotube composites as multifunctional substrates for in situ actuation of differentiation of human neural stem cellsJohn Landers, Jeffrey T Turner, Greg Heden, et al.
Journal of the American Dietetic Association|October 1, 1996
Assessing fruit and vegetable consumption in a 5 a day study targeting rural blacks: the issue of portion sizeM Kramish Campbell, B Polhamus, J W McClelland, et al.
Drug Discovery Today|August 29, 2003
Drug discovery in the ubiquitin regulatory pathwayBrian R Wong, Francesco Parlati, Kunbin Qu, et al.
The Journal of Rheumatology|August 1, 1995
Patient utilities in fibromyalgia and the association with other outcome measuresC Bakker, M Rutten, M van Santen-Hoeufft, et al.
The Journal of Biological Chemistry|June 6, 1998
Protease resistance of syntaxin.SNAP-25.VAMP complexes. Implications for assembly and structureM A Poirier, J C Hao, P N Malkus, et al.
Plos One|January 5, 2012
Molecular mechanisms of bortezomib resistant adenocarcinoma cellsErika Suzuki, Susan Demo, Edgar Deu, et al.
Pageof 57